| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/29/2002 | US20020119467 Amplifying enzymatic activity of polymerase; generate nucleotide sequence reaction mixture, incubate with polymerase and ribonucleic acid binding protein, monitor adjustment in polymerase biosynthetic activity |
| 08/29/2002 | US20020119462 Molecular toxicology modeling |
| 08/29/2002 | US20020119461 High fidelity polymerases and uses thereof |
| 08/29/2002 | US20020119459 Optical sorting method |
| 08/29/2002 | US20020119455 Methods and products for analyzing polymers |
| 08/29/2002 | US20020119452 Nucleotide sequences coding protein for use in the diagnosis and treatment of osteoarthritis |
| 08/29/2002 | US20020119450 Fluorimetric detection system of a nucleic acid |
| 08/29/2002 | US20020119449 Rna-dependent rna polymerase functioning preferably on rna matrix and promoter-dependent transcription process with said rna- dependent rna polymerase |
| 08/29/2002 | US20020119447 Non-a,non-b,non-c,non-c,non-d,non-e hepatitis reagents and methods for their use |
| 08/29/2002 | US20020119189 Nucleosome-based anti-tumor compositions |
| 08/29/2002 | US20020119158 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/29/2002 | US20020119156 Polynucleotides and polypeptides which are diagnostic markers for lung cance |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119149 Multivalent T cell receptor complexes |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119137 Useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass |
| 08/29/2002 | US20020119127 Method and system for optimizing minigenes and peptides encoded thereby |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | US20020117396 N-((4-(3-ferrocenecarboxamidopropyl)piperazinyl)-propyl)-1, 8-naphthalene imide |
| 08/29/2002 | DE10162386A1 Für das rpsL-Gen kodierende Nukleotidsequenzen For the rpsL gene coding nucleotide sequences |
| 08/29/2002 | DE10109517A1 Verfahren zur Herstellung von Genbibliotheken Process for the preparation of gene libraries |
| 08/29/2002 | DE10108100A1 Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse Use supersekretierbarer peptides in processes for their preparation and parallel improvement of Exportate one or more other polypeptides of interest |
| 08/29/2002 | CA2750033A1 Methods and probes for the detection of cancer |
| 08/29/2002 | CA2698079A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2576136A1 Novel calcium-independent phospholipases a2, genes thereof and promoter of the same |
| 08/29/2002 | CA2473197A1 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | CA2445796A1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | CA2442293A1 Zinc finger binding domains for nucleotide sequence ann |
| 08/29/2002 | CA2441444A1 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 08/29/2002 | CA2440008A1 Rat toxicologically relevant genes and uses thereof |
| 08/29/2002 | CA2438822A1 Novel gene and uses therefor to modify pasture qualities of crops |
| 08/29/2002 | CA2438818A1 Rapid production of monoclonal antibodies |
| 08/29/2002 | CA2438775A1 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | CA2438769A1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | CA2438628A1 Artificial proteins with reduced immunogenicity |
| 08/29/2002 | CA2438550A1 A method of identifying differences between nucleic acid molecules |
| 08/29/2002 | CA2438521A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 08/29/2002 | CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | CA2438390A1 Methods of modifying eukaryotic cells |
| 08/29/2002 | CA2438371A1 Histidine phosphatase interacting protein of 120 kd |
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438322A1 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 08/29/2002 | CA2438247A1 A microchip electrospray device and column with affinity adsorbents and use of the same |
| 08/29/2002 | CA2438245A1 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2438133A1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | CA2438119A1 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | CA2438066A1 Magnetic isolation and purification of nucleic acids |
| 08/29/2002 | CA2438012A1 H. influenzae antigen basb213 |
| 08/29/2002 | CA2437937A1 Method for identifying herbicidally active substances |
| 08/29/2002 | CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | CA2437161A1 Anti-interferon-.alpha. antibodies |
| 08/29/2002 | CA2436516A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | CA2433841A1 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | CA2433408A1 Method for purification of soluble ssao |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | CA2432489A1 Detection of protein conformation using a split ubiquitin reporter system |
| 08/29/2002 | CA2432375A1 Lipolytic enzyme genes |
| 08/29/2002 | CA2405883A1 Engineering fungi for the utilisation of l-arabinose |
| 08/28/2002 | EP1235073A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 08/28/2002 | EP1234883A1 Expression control sequence |
| 08/28/2002 | EP1234882A1 GlmU POLYPEPTIDE AND DNA ENCODING THE POLYPEPTIDE |
| 08/28/2002 | EP1234881A1 Dna fragment having promoter function |
| 08/28/2002 | EP1234880A1 Novel protein tab2 |
| 08/28/2002 | EP1234879A2 Human nucleic acid sequences from prostate tumour tissue |
| 08/28/2002 | EP1234878A1 Use of disease-associated gene |
| 08/28/2002 | EP1234877A1 Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |
| 08/28/2002 | EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 08/28/2002 | EP1234875A1 Novel metalloprotease having aggrecanase activity |
| 08/28/2002 | EP1234874A1 L-cysteine producing bacterium and method for producing L-cysteine |
| 08/28/2002 | EP1234832A2 Isolation of nucleic acids |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234179A2 Naive screening method |
| 08/28/2002 | EP1234060A2 Evaluating and predicting clinical outcomes by gene expression analysis |
| 08/28/2002 | EP1234058A2 Nucleic acid probe arrays |
| 08/28/2002 | EP1234054A1 Methods for detecting polypeptides regulating signal transduction pathways |
| 08/28/2002 | EP1234048A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 08/28/2002 | EP1234047A1 Drug inducible system and use thereof |
| 08/28/2002 | EP1234046A2 Udp-glucose:aglycon-glucosyltransferase |
| 08/28/2002 | EP1234045A2 Maize mip synthase promoter |
| 08/28/2002 | EP1234044A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234042A1 Protein 27875, a human adam-ts homolog |
| 08/28/2002 | EP1234041A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234039A2 85kDa NEISSERIAL ANTIGEN |
| 08/28/2002 | EP1234038A1 Nucleic acid construct for optimized production of products |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234036A2 Compositions and methods for the treatment of immune related diseases |
| 08/28/2002 | EP1234035A1 Human cytokine receptor |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234033A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 08/28/2002 | EP1234032A1 Novel nucleic acid and polypeptide |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234029A2 Surface modified supporting materials for binding biological materials, method for the production and use thereof |
| 08/28/2002 | EP1234028A2 Preparation of sequence libraries from non-denatured rna and kits therefor |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234026A1 Method and apparatus for selectively targeting specific cells within a cell population |